Venture Kick

15 years of changing the world - one startup a time: we celebrate all the brave entrepreneurs, the teams, investors, and supporters for the incredible journey together with Venture Kick! Thank you all - you are truly kicking it!!! Read more about our history, shaping the future: https://lnkd.in/eSNkfeuP #SwissStartups #VentureKick

CHF 10’000 for Dyneo Technologies SA, Myriad Optics, wearefreemovers GmbH and Winduction AG. These four projects were selected at Venture Kick's first financial and entrepreneurial support stage. https://lnkd.in/gbKVT2yr Meet the 4 successful projects:   Mael Perret (CEO) and Max Carrel (CTO) | Dyneo Technologies SA - Data-driven solutions for sustainable district heating and cooling networks. https://en.dyneo.ch/   Co-Founders: Marwan El Chazli and Fahradin Mujovi | Myriad Optics - Faster bacterial pathogen identification.   Fabio Pellini (CPO) and Andrea Pellini (CEO) | wearefreemovers GmbH - Revolutionizing Global Education Access. https://lnkd.in/eAgSm3Ni Co-Founders: Sonam Bhuka (COO) and Sylvain Fricker (CTO) | Winduction AG - Creating Enabling EVs to charge wirelessly while driving or standing. https://lnkd.in/gGcYHM_P #VentureKick #SwissStartups

Venture Kick alumni KITRO secures funding to advance food waste reduction efforts. https://lnkd.in/gyzX6S4K. Congratulations to founders Naomi MacKenzie and Anastasia Hofmann! KITRO, a technology-driven company focused on reducing food waste, has completed its latest funding round. The capital will support its mission to broaden its market presence and deliver measurable progress in combating food waste. About: KITRO is a Swiss company that tackles global food waste through data-driven solutions. Using artificial intelligence, KITRO provides an automated system to track and analyze food waste in professional kitchens, helping food service operators reduce waste, save costs, and meet sustainability goals. #VentureKick #SwissStartups 

CHF 40’000 for Adjust Medical, JOSEPHA, and dEEGtal. These three projects were selected at Venture Kick's second financial and entrepreneurial support stage. https://lnkd.in/dv7vEGgD   Meet the 3 winning startups and their founders:   Co-Founders: Youssef Biadillah, Vitaliy Verin, Giovanni Leo, and Aristotelis Panos | Adjust Medical - A new differentiated treatment fo Mitral Valve Regurgitation. https://lnkd.in/eagzgivK   Silvan Weder (CEO) and Josef Gitterle (CPO) | JOSEPHA - Providing personalized advice on every product on the internet. https://lnkd.in/duXGGEUr   Stefano Gallotto (CTO), Margitta Seeck (Co-Founder and Advisor), and Eric Ménétré (CEO) | dEEGtal - AI-powered epilepsy diagnosis software for rapid results. https://lnkd.in/dgZx2bAr   #VentureKick #SwissStartups

Venture Kick alumni Splint Invest (Mark Investment Holding) exceeds crowdfunding target with CHF 2.5 million in Pre-Funding Round. https://lnkd.in/d5ce4YsY Zug-based startup Splint Invest has raised CHF 2.5 million from 815 investors in its Pre-Funding Round, surpassing its goal and cancelling the planned public campaign. The company has now secured a total of CHF 4 million for its European expansion. About: The platform, which offers investments in over 200 assets, has attracted over 15,000 investors, with a third of them coming from the EU. So far, more than EUR 21 million has been invested in tokenized shares, known as "Splints." The company is on track for impressive growth, projecting a 280% increase in annual revenue compared to last year. #VentureKick #SwissStartups 

Venture Kick alumni Spectroplast AG completes Series A Round to support its silicone 3D printing technology. https://lnkd.in/dPD4UYM2 Spectroplast AG, a pioneer in Silicone Additive Manufacturing, has secured fresh capital in a Series A round led by HZG Group, with continued support from AM Ventures. This strategic investment empowers Spectroplast to broaden its applications and deliver even greater support to industries prioritizing biocompatibility. With silicone’s versatility and its critical role in manufacturing, from gaskets to medical devices, Spectroplast is well-positioned to drive the next wave of innovation in 3D printing. About: Spectroplast AG has developed the first Silicone 3D Printing technology to produce customised live- enhancing prosthetics and life-saving medical implants. The ETH Zürich spinoff has a positive impact on society by providing patient-specific solutions through its pioneering Silicone Additive Manufacturing. #VentureKick #MedTech #SwissStartups 

CALDRE receives CHF 150’000 to develop innovative liver disease therapeutics. https://lnkd.in/dSzGTHUz   Congratulations to amazing team of founders: Dr. Felix Alexander Baier, Dr. Adrian Keogh, Dr. Tarik Elamri and Corina Krummenacher About CALDRE - Problem & Market: The liver produces 800 ml of bile daily; Cholestasis, caused by autoimmune diseases or unhealthy lifestyles, leads to serious liver injury and metabolic issues, necessitating 10% of liver transplants. Targeting chronic cholestatic diseases without effective treatments, they address a $2.5B market for 370,000 patients in Europe, the US, China, and Japan. Solution: their novel therapeutic target uses liver-specific GalNAc siRNA, preventing liver injury in cholestasis models. This approach provides improved efficacy and safety. #SwissStartups #VentureKick

Huge congratulations to 20-year-old former Venture Kick winner Yohan Hadji on his successful exit with R2Home! Yohan's glidersonde, originally developed at EPFL and now rebranded as Meteoglider, has officially joined the Meteomatics family, advancing sustainable solutions in atmospheric sensing. About: Each year, 600,000 radiosondes are launched globally to gather atmospheric data for weather forecasts, but most are lost when balloons burst, causing significant environmental and economic costs (USD 100M annually). R2HOME offers a groundbreaking solution: a gliding robot that ensures radiosondes return safely to a precise landing point. This preserves the equipment for reuse, enabling more launches and better data collection for improved weather forecasts in a world where accurate predictions are increasingly vital. #VentureKick #SwissStartups #Exit #StartupExit

Venture Kick startup Oncobit AG secures CHF 1.47 million to advance precision cancer solutions. https://lnkd.in/dVtR9Fxb The Swiss-based precision medicine company Oncobit has raised CHF 1.47 million in its Pre-Series A financing round. The funds will support the company's product development initiatives and growth strategy, strengthening its focus on delivering advanced solutions in cancer care. About: Oncobit, a spinoff from the Universitätsspital Zürich, has developed a scalable, data-driven cancer monitoring platform that uses liquid biopsies to detect cancer markers with precision. Its cloud-based software, trained on healthy and patient data, ensures robust, standardized result reporting. Focused initially on melanoma (IVDR certified), Oncobit has gained traction in Europe, securing commercial contracts with a global pharma company, a Swiss hospital, and implementing its products in three leading German cancer centers. #VentureKick #SwissStartups

CHF 40’000 for intonate., Spacetalk, and UNOMR. These three projects were selected at Venture Kick's second financial and entrepreneurial support stage. https://lnkd.in/dUasXKCT Meet the 3 winning startups and their founders: Tim Gmünder (COO), Julian Sutter (CEO), and Livio Schläpfer (CTO) | intonate. -Responsibly leveraging AI to improve the healthcare system. https://lnkd.in/d_Tfmb2N   Jérôme Bontron (CCO), Elisabeth Tripod-Fatio (CSO), Michel Fischer (CTO) and Dr. Benjamin Guyot (CEO) | Spacetalk - Coordination of space traffic. https://lnkd.in/dt6CczM3   Julian Hengsteler (CTO), Julia Wagner (COO), and Til Schlotter (CEO) | UNOMR - Single biomolecule sensors to revolutionize medical research. https://lnkd.in/dVsA93XQ     #VentureKick #SwissStartups